DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (95)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 95   Next >>

Possible PEG-Intron side effects in

Reported by a physician from Italy on 2012-08-22

Patient:

Reactions: Multi-Organ Failure, Bronchopneumonia, Respiratory Acidosis, Pancytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron

PEG-Intron
    Dosage: 1200 mg, qw
    Indication: Hepatitis C
    Start date: 2012-04-23
    End date: 2012-07-02

Rebetol
    Dosage: 1200 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-23
    End date: 2012-07-07

Victrelis
    Dosage: unk, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-07-07

Other drugs received by patient: Aspirin



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-22

Patient:

Reactions: Confusional State, Affect Lability, Completed Suicide, Platelet Count Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram, qw
    Start date: 2012-05-29
    End date: 2012-06-05

PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-05-23
    End date: 2012-05-23

Rebetol
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-23
    End date: 2012-06-01



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-21

Patient:

Reactions: Haemoglobin Decreased, Hepatic Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.8mcg/kg/week

PEG-Intron
    Dosage: 1.0mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-02-24

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-04-25

Rebetol
    Administration route: Oral
    Start date: 2012-04-26

Telavic
    Administration route: Oral
    Start date: 2012-05-14
    End date: 2012-06-01

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-05-13



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from Korea, Republic of on 2012-08-15

Patient:

Reactions: Major Depression

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

PEG-Intron
    Dosage: 1 df, qw
    Indication: Hepatitis C
    Start date: 2012-04-05
    End date: 2012-05-30

Ribavirin
    Dosage: 5 df, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-05
    End date: 2012-05-30

Ribavirin
    Dosage: 5 df, bid
    Administration route: Oral
    Start date: 2012-04-05
    End date: 2012-05-30



Possible PEG-Intron side effects in male

Reported by a individual with unspecified qualification from France on 2012-08-09

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Tooth Disorder

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

PEG-Intron
    Dosage: 30 ?g, qw
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Placebo
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Placebo
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-07

Patient:

Reactions: Hepatic Cirrhosis

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1 df, qw
    Indication: Hepatitis C

Rebetol
    Indication: Hepatitis C



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from Colombia on 2012-08-07

Patient:

Reactions: Vomiting, Diabetes Mellitus, Diabetic Coma, Dizziness, Asthenia, Blood Glucose Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Omeprazole; Isoniazid; Acetaminophen; Ribavirin; Propranolol; Levothyroxine Sodium



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Greece on 2012-08-01

Patient:

Reactions: Dyspnoea, Fatigue, Pulmonary Embolism, Pleural Effusion, Pyrexia, Cardiac Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 unk, unk
    Indication: Hepatitis C
    Start date: 2011-09-20
    End date: 2012-07-03

Rebetol
    Dosage: 1200 mg, unk
    Indication: Hepatitis C
    Start date: 2011-09-20
    End date: 2012-07-03



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-29

Patient:

Reactions: Death

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Victrelis



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27

Patient:

Reactions: Periorbital Oedema, Vomiting, Nausea, Insomnia, Disturbance in Attention

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 ?g, qw
    Indication: Hepatitis C
    Start date: 2012-01-23

Ribasphere
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2012-01-27

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-21

Other drugs received by patient: Zoloft; Neupogen; Procrit



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-07-27

Patient:

Reactions: Weight Decreased, Hypogeusia, Chills, Oropharyngeal Pain, Death, Cheilitis, Feeling of Body Temperature Change, Pharyngitis, White Blood Cell Count Decreased, Dysphagia, Vomiting, Stomatitis, Anaemia, Full Blood Count Decreased, Haemoglobin Decreased, Dysgeusia, Diarrhoea, Dehydration, Asthenia, Aphonia, Influenza Like Illness

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-04
    End date: 2012-06-29

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-04
    End date: 2012-06-29

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-08
    End date: 2012-06-29



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-07-26

Patient:

Reactions: Anaemia, Thrombocytopenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 180 microgram, qw
    Indication: Hepatitis C
    Start date: 2011-10-21

Rebetol
    Dosage: 600 mg, qd
    Start date: 2012-05-16

Rebetol
    Dosage: 800 mg, qd
    Start date: 2012-05-03
    End date: 2012-05-15

Rebetol
    Dosage: 1200 mg, qd
    Indication: Hepatitis C
    Start date: 2011-10-21
    End date: 2012-05-02

Victrelis
    Dosage: 2400 mg, qd
    Indication: Hepatitis C
    Start date: 2011-12-21



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-26

Patient:

Reactions: Death

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Victrelis



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from France on 2012-07-26

Patient:

Reactions: Tooth Disorder

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

PEG-Intron
    Dosage: 30 ?g, qw
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Placebo
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-25

Patient:

Reactions: Dyspnoea, Syncope, Wrong Technique in Drug Usage Process, Blood Pressure Decreased, Asthenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 micrograms, qw
    Indication: Hepatitis C
    Start date: 2012-05-01

Rebetol
    Indication: Hepatitis C

Other drugs received by patient: Lisinopril; Ondansetron; Effexor; Synthroid; Paxil; Tranxene



Possible PEG-Intron side effects in

Reported by a physician from Italy on 2012-07-25

Patient:

Reactions: Multi-Organ Failure, Bronchopneumonia, Respiratory Acidosis, Pancytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron

PEG-Intron
    Dosage: 1200 mg, qw
    Indication: Hepatitis C
    Start date: 2012-04-23
    End date: 2012-07-02

Rebetol
    Dosage: 1200 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-23
    End date: 2012-07-07

Victrelis
    Dosage: unk, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-07-07

Other drugs received by patient: Aspirin



Possible PEG-Intron side effects in

Reported by a physician from Greece on 2012-07-24

Patient:

Reactions: Dyspnoea, Fatigue, Pleural Effusion, Pulmonary Embolism, Pyrexia, Cardiac Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 unk, unk
    Indication: Hepatitis C
    End date: 2012-07-03

Rebetol
    Dosage: 1200 microgram, unk
    Indication: Hepatitis C
    End date: 2012-07-03



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-20

Patient:

Reactions: Hypogeusia, Glossodynia, Tinnitus, Hypoaesthesia Oral

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Ribavirin
    Indication: Hepatitis C

Victrelis
    Dosage: 800 mg, q8h
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11



Possible PEG-Intron side effects in

Reported by a physician from Germany on 2012-07-20

Patient:

Reactions: Vomiting, Renal Failure, Sepsis, Urinary Tract Infection, Hepatic Failure

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Copegus
    Dosage: 1600 mg
    Indication: Hepatitis C
    Start date: 2012-01-05
    End date: 2012-06-19

PEG-Intron
    Dosage: 180 micg, qw
    Indication: Hepatitis C
    Start date: 2012-01-05
    End date: 2012-06-19

Victrelis
    Dosage: 3 x 800
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-06-19

Other drugs received by patient: Citalopram Hydrobromide; Haloperidol; Metoclopramide; Lercanidipine; Mirtazapin Stada; Ramipril



Possible PEG-Intron side effects in

Reported by a physician from Netherlands on 2012-07-19

Patient:

Reactions: Pancreatitis

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Rebetol
    Indication: Hepatitis C



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-19

Patient:

Reactions: Bowel Movement Irregularity, Tinnitus, Anaemia, Feeling Hot, Loss of Consciousness

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-07-22

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-07-22

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-08-20



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from Colombia on 2012-07-18

Patient:

Reactions: Atelectasis, Respiratory Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram, qd
    Start date: 2012-06-22
    End date: 2012-06-24

PEG-Intron
    Dosage: 80 microgram, qd
    Indication: Hepatitis B
    Start date: 2012-06-15



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-18

Patient:

Reactions: Drug Dose Omission, Burning Sensation, Pruritus, DRY Skin, Erythema

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Ondansetron; Prilosec; Metformin Hydrochloride; Ibuprofen



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient:

Reactions: Influenza Like Illness

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 a?g, qw
    Indication: Hepatitis C
    Start date: 2012-01-01

Ribavirin
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Antiviral (Unspecified)



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient:

Reactions: Malaise, Injection Site Rash

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from Germany on 2012-07-17

Patient:

Reactions: Aphthous Stomatitis, Pruritus, Stomatitis, Anaemia, Aggression, Middle Insomnia, Syncope, Mood Altered, NO Therapeutic Response, Thrombocytopenia, Leukopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Start date: 2011-10-28
    End date: 2011-12-07

PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2010-08-20
    End date: 2010-11-29

PEG-Intron
    Dosage: 80 a?g, qw
    Start date: 2011-12-01

PEG-Intron
    Dosage: 64 a?g, qw

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Start date: 2011-10-28

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2010-08-20
    End date: 2010-11-29

Victrelis
    Dosage: 2400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-23

Other drugs received by patient: Opipramol Hydrochloride; Citalopram Hydrobromide; Amitriptyline HCL



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-16

Patient:

Reactions: Injury Associated With Device

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-07-11

Patient:

Reactions: Irritability, Completed Suicide

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-05-01
    End date: 2012-06-01

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-01
    End date: 2012-06-01



Possible PEG-Intron side effects in

Reported by a physician from Germany on 2012-07-11

Patient:

Reactions: Vomiting, Renal Failure, Urinary Tract Infection, Hepatic Failure

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Copegus
    Dosage: 1600 mg
    Indication: Hepatitis C
    Start date: 2012-01-05
    End date: 2012-06-19

PEG-Intron
    Dosage: 180 micg, qw
    Indication: Hepatitis C
    Start date: 2012-01-05
    End date: 2012-06-19

Victrelis
    Dosage: 3 x 800
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-06-19

Other drugs received by patient: Ramipril; Haloperidol; Metoclopramide; Lercanidipine; Mirtazapin Stada; Citalopram Hydrobromide



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from United States on 2012-07-11

Patient:

Reactions: Inappropriate Schedule of Drug Administration

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014